EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 383 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,420 | -5.5% | 419,214 | -0.2% | 0.02% | -4.8% |
| Q1 2024 | $9,972 | -1.4% | 420,243 | -0.3% | 0.02% | -8.7% |
| Q4 2023 | $10,109 | +12.6% | 421,377 | +2.6% | 0.02% | +4.5% |
| Q3 2023 | $8,975 | +17.4% | 410,760 | +2.7% | 0.02% | +29.4% |
| Q2 2023 | $7,645 | -4.4% | 400,041 | -2.9% | 0.02% | -10.5% |
| Q1 2023 | $7,997 | +20.7% | 411,987 | -0.3% | 0.02% | +18.8% |
| Q4 2022 | $6,626 | -99.9% | 413,103 | +0.1% | 0.02% | -5.9% |
| Q3 2022 | $6,471,000 | -21.8% | 412,704 | +3.8% | 0.02% | -15.0% |
| Q2 2022 | $8,278,000 | -5.2% | 397,615 | +3.2% | 0.02% | +11.1% |
| Q1 2022 | $8,735,000 | +26.5% | 385,333 | +2.0% | 0.02% | +38.5% |
| Q4 2021 | $6,903,000 | -4.3% | 377,643 | +10.6% | 0.01% | -13.3% |
| Q3 2021 | $7,215,000 | +15.4% | 341,311 | -0.5% | 0.02% | +15.4% |
| Q2 2021 | $6,252,000 | -20.6% | 343,128 | -1.5% | 0.01% | -23.5% |
| Q1 2021 | $7,870,000 | +6.5% | 348,392 | -5.4% | 0.02% | +6.2% |
| Q4 2020 | $7,390,000 | -18.4% | 368,189 | -0.6% | 0.02% | -27.3% |
| Q3 2020 | $9,054,000 | +12.3% | 370,289 | +9.0% | 0.02% | +10.0% |
| Q2 2020 | $8,064,000 | +49.1% | 339,689 | +8.2% | 0.02% | +25.0% |
| Q1 2020 | $5,407,000 | -2.8% | 313,989 | -0.5% | 0.02% | +23.1% |
| Q4 2019 | $5,562,000 | +0.7% | 315,689 | +1.1% | 0.01% | -7.1% |
| Q3 2019 | $5,523,000 | -13.7% | 312,289 | +4.3% | 0.01% | -12.5% |
| Q2 2019 | $6,398,000 | -9.1% | 299,389 | +1.2% | 0.02% | -11.1% |
| Q1 2019 | $7,040,000 | +63.6% | 295,789 | +35.2% | 0.02% | +50.0% |
| Q4 2018 | $4,304,000 | +11.0% | 218,827 | 0.0% | 0.01% | +33.3% |
| Q3 2018 | $3,878,000 | -17.6% | 218,827 | 0.0% | 0.01% | -18.2% |
| Q2 2018 | $4,709,000 | – | 218,827 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |